Onconova Therapeutics, Inc. (ONTX) Financials

ONTX Assets vs Liabilities

DateAssetsLiabilities
2023-09-30 27.0 million 12.5 million
2023-06-30 30.5 million 11.6 million
2023-03-31 35.1 million 12.2 million
2022-12-31 39.4 million 11.1 million

ONTX Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2023-09-30 -4.5 million 360000
2023-06-30 -4.5 million 273000
2023-03-31 -4.5 million 336000
2022-12-31 -3.9 million 330000

ONTX Net Income

No data available :(

ONTX Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2023-09-30 25.2 million - -
2023-06-30 29.7 million - -
2023-03-31 34.2 million - -
2022-12-31 38.8 million - -

ONTX Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2023-09-30 21.0 million
2023-06-30 21.0 million
2023-03-31 21.0 million
2022-12-31 20.9 million

ONTX Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2023-09-30 14000 2.5 million 2.7 million -
2023-06-30 - 2.5 million 2.2 million -
2023-03-31 - 4.1 million 2.1 million -
2022-12-31 - 3.8 million 2.0 million -

ONTX Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2023-09-30 57000 5000
2023-06-30 57000 4000
2023-03-31 56000 3000
2022-12-31 56000 4000

ONTX

Price: $1

52 week price:
0.55
1.45

Earnings Per Share: -0.96 USD

P/E Ratio: -0.68

Exchange: NCM

Sector: Healthcare

Industry: Biotechnology

Volume: 74400

Ebitda: -6.7 million

Market Capitalization: 17.6 million

Links: